Medication Guide Letairis® (le-TAIR-is) (ambrisentan)Tablets

First Page		Document Content
Progesterone Combined oral contraceptive pill Birth control Menopause Pregnancy Menstrual cycle Intrauterine device Emergency contraception Puberty Endocrine system Hormonal contraception Medicine		Medication Guide Letairis® (le-TAIR-is) (ambrisentan)Tablets Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 407,86 KB Share Document on Facebook

	Menopause Publishes Pivotal Trial Results for Brisdelle™ (Paroxetine) Capsules, an FDA-Approved Non-Hormonal Therapy for Vasomotor Symptoms Associated with Menopause Miami, FL and New York, NY, September 18, 2013 – N DocID: 1vh4h - View Document
	Work and the Menopause: A Guide for Managers Introduction: Older women workers Women comprise approximately half (47 percent) of the UK’s workforce. About 3.5 million are women aged 50 and over. Occupational health iss DocID: 1udvc - View Document
	Institute of Work, Health & Organisations http://www.nottingham.ac.uk/iwho Women’s Experience of Working through the Menopause DocID: 1tQHM - View Document
	17TH ANNUAL FALL CONFERENCE ON INTEGRATIVE MEDICINE IN WOMEN’S HEALTH Including topics on: Nutrition, Perimenopause & Menopause, DocID: 1sahn - View Document
	MR#:________________ Name: ________________________________________________ Date: _________________________ Age: __________________ DocID: 1rbzC - View Document